Jim Simons Red Hill Biopharma Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.14 - $695.9 $48,923 - $243 Million
349,453 New
349,453 $49,000
Q3 2021

Nov 12, 2021
SELL
$4.55 - $10.36 $90,449 - $205,946
-19,879 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$5.98 - $7.51 $118,876 - $149,291
19,879 New
19,879 $137,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email